ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025
A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effects.
Jaime R Merchan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.